Cytomx Therapeutics Stock Price Prediction
CTMX Stock | USD 2.18 0.01 0.46% |
Oversold Vs Overbought
49
Oversold | Overbought |
CytomX Therapeutics stock price prediction is an act of determining the future value of CytomX Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of CytomX Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of CytomX Therapeutics and does not consider all of the tangible or intangible factors available from CytomX Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with CytomX Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting CytomX Therapeutics' stock price prediction:EPS Estimate Current Year (0.19) | EPS Estimate Next Year (0.37) | Wall Street Target Price 2.9 | EPS Estimate Current Quarter (0.03) | Quarterly Revenue Growth 0.322 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of CytomX Therapeutics based on different types of headlines from major news networks to social media. The CytomX stock price prediction module provides an analysis of price elasticity to changes in media outlook on CytomX Therapeutics over a specific investment horizon. Using CytomX Therapeutics hype-based prediction, you can estimate the value of CytomX Therapeutics from the perspective of CytomX Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards CytomX Therapeutics using CytomX Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards CytomX using crowd psychology based on the activity and movement of CytomX Therapeutics' stock price.
CytomX Therapeutics Short Interest
A significant increase or decrease in CytomX Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards CytomX. Short interest can provide insight into the potential direction of CytomX Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long CytomX Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about CytomX Therapeutics and may potentially protect profits, hedge CytomX Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.5699 | Short Percent 0.0525 | Short Ratio 1.97 | Shares Short Prior Month 1.6 M | 50 Day MA 1.8818 |
CytomX Therapeutics Hype to Price Pattern
Investor biases related to CytomX Therapeutics' public news can be used to forecast risks associated with an investment in CytomX. The trend in average sentiment can be used to explain how an investor holding CytomX can time the market purely based on public headlines and social activities around CytomX Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of CytomX Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about CytomX Therapeutics.
CytomX Therapeutics Implied Volatility | 69.66 |
CytomX Therapeutics' implied volatility exposes the market's sentiment of CytomX Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if CytomX Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that CytomX Therapeutics stock will not fluctuate a lot when CytomX Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in CytomX Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in CytomX Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying CytomX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CytomX Therapeutics after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CytomX |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CytomX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CytomX Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of CytomX Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CytomX Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CytomX Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
CytomX Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting CytomX Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CytomX Therapeutics' historical news coverage. CytomX Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 6.34, respectively. We have considered CytomX Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CytomX Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of CytomX Therapeutics is based on 3 months time horizon.
CytomX Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CytomX Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CytomX Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CytomX Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.59 | 6.30 | 0.01 | 0.05 | 11 Events / Month | 3 Events / Month | In about 11 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.18 | 0.00 | 0.00 |
|
CytomX Therapeutics Hype Timeline
CytomX Therapeutics is currently traded for 2.18. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.05. CytomX is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.59%. %. The volatility of related hype on CytomX Therapeutics is about 7112.9%, with the expected price after the next announcement by competition of 2.13. About 49.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.01. CytomX Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 11 days. Check out CytomX Therapeutics Basic Forecasting Models to cross-verify your projections.CytomX Therapeutics Related Hype Analysis
Having access to credible news sources related to CytomX Therapeutics' direct competition is more important than ever and may enhance your ability to predict CytomX Therapeutics' future price movements. Getting to know how CytomX Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CytomX Therapeutics may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
EPGG | Empire Global Gaming | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
GME | GameStop Corp | 0.01 | 8 per month | 0.00 | (0.13) | 4.75 | (4.94) | 30.45 | |
EVVTY | Evolution Gaming Group | 0.00 | 0 per month | 2.05 | (0.02) | 3.24 | (3.01) | 16.20 | |
NCMI | National CineMedia | (0.05) | 6 per month | 2.78 | 0.06 | 6.03 | (4.86) | 24.88 | |
SLOFF | Solstad Offshore ASA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
MYPS | Playstudios | 0.04 | 7 per month | 3.45 | (0.02) | 5.91 | (6.41) | 14.24 | |
TSQ | Townsquare Media | (0.62) | 7 per month | 2.30 | (0.02) | 3.58 | (3.89) | 12.69 |
CytomX Therapeutics Additional Predictive Modules
Most predictive techniques to examine CytomX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CytomX using various technical indicators. When you analyze CytomX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About CytomX Therapeutics Predictive Indicators
The successful prediction of CytomX Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CytomX Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CytomX Therapeutics based on analysis of CytomX Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CytomX Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CytomX Therapeutics's related companies. 2023 | 2024 (projected) | Dividend Yield | 0.0336 | 0.0299 | Price To Sales Ratio | 1.13 | 1.07 |
Story Coverage note for CytomX Therapeutics
The number of cover stories for CytomX Therapeutics depends on current market conditions and CytomX Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CytomX Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CytomX Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
CytomX Therapeutics Short Properties
CytomX Therapeutics' future price predictability will typically decrease when CytomX Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CytomX Therapeutics often depends not only on the future outlook of the potential CytomX Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CytomX Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 73.8 M | |
Cash And Short Term Investments | 174.5 M |
Check out CytomX Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for CytomX Stock analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is CytomX Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytomX Therapeutics. If investors know CytomX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytomX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.322 | Return On Assets (0.02) | Return On Equity (54.75) |
The market value of CytomX Therapeutics is measured differently than its book value, which is the value of CytomX that is recorded on the company's balance sheet. Investors also form their own opinion of CytomX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytomX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytomX Therapeutics' market value can be influenced by many factors that don't directly affect CytomX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytomX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytomX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytomX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.